CI 977

Known as: CI-977 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2004
051019902004

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Earlier reports indicate that kappa-opioid agonists may be especially potent in the formalin test of tonic nociception, and that… (More)
Is this relevant?
1994
1994
The diuretic effects, pharmacokinetics, and safety of CI-977, a new centrally acting selective kappa-opioid agonist, were… (More)
Is this relevant?
1994
1994
The effect of the neuroprotective kappa opioid agonist CI-977 on glutamate (GLU)-stimulated calcium signaling was studied in… (More)
Is this relevant?
1994
1994
The opioid antagonist effects of systemically administered nor-binaltorphimine (nor-BNI) were evaluated against the kappa… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
1994
1994
The effects of the kappa-opioid agonist CI-977 upon local cerebral glucose utilization have been examined in conscious, lightly… (More)
Is this relevant?
1993
1993
The neuroprotective efficacy of the kappa-opioid agonist enadoline (CI-977) was examined in two acute rat models of focal… (More)
Is this relevant?
1993
1993
The effects of the kappa-1 opioid receptor agonist (5R)-(5 alpha,7 alpha,8 beta)-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4,5… (More)
Is this relevant?
1992
1992
Intracellular recordings were made from neurons in a rat locus coeruleus slice preparation in vitro. A postsynaptic potential was… (More)
Is this relevant?
1992
1992
CI-977 is a selective, nonpeptide kappa opioid agonist. In rhesus monkeys, CI-977 is a potent antinociceptive agent against… (More)
Is this relevant?
1990
1990
1. CI-977 is a new, nonpeptide kappa-opioid compound that has been synthesized and its pharmacological properties determined in a… (More)
Is this relevant?